The Effect of Kinesio Taping Application for Dysmenorrhea
NCT ID: NCT02663050
Last Updated: 2016-02-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
150 participants
INTERVENTIONAL
2016-02-29
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Kinesio taping group
only Kinesio taping treatment group
Kinesio taping
Patients will be taped for four days , ıt will start at the begining of the Dysmenorrhea
NSAID treatment group
only NSAIDs taking group
NSAID's
twice a daily
Combination treatment group
NSAIDs plus Kinesio taping group
Kinesio taping
Patients will be taped for four days , ıt will start at the begining of the Dysmenorrhea
NSAID's
twice a daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Kinesio taping
Patients will be taped for four days , ıt will start at the begining of the Dysmenorrhea
NSAID's
twice a daily
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* surgical abdominal emergency
* metabolic or inflammatory illnesses or cardiovascular diseases,
* endocrine disorders such as diabetes, thyroid disorders, androgen excess (hyperprolactinemia, uncontrolled thyroid disease, congenital adrenal hyperplasia, Cushing's syndrome, androgen-secreting tumor),
* smokers
* using pharmaceutical agents such as anti-inflammatory agents that could possibly impact on endocrine and liver enzymes
* musculoskeletal pain
* inguinal hernia
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saglik Bilimleri Universitesi Gulhane Tip Fakultesi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mustafa Ozturk
M.D.,Obstetrics and Gynecology, Specialist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mustafa Öztürk, M.D.
Role: PRINCIPAL_INVESTIGATOR
Etimesgut Military Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Mustafa
Identifier Type: -
Identifier Source: org_study_id